Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …